Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-06

Clinical Trial Update: Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tranexamic acid to prevent postpartum hemorrhage after vaginal delivery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Hospital, Angers | Conditions: Immediate Postpartum Hemorrhage | Phase 3 | Status: COMPLETED